Bone Grafts Market in the United States to Reach $3.18 Billion by 2015, According to New Report by Global Industry Analysts

Share Article

Greater fracture incidence, rising number of spinal fusion procedures that incorporate biologic solutions, commercialization of new, next generation bone growth factors and positive clinical outcomes, will drive bone grafts market in United States to reach $3.18 billion by 2015.

Bone Grafts: A US Market Report

Globally, approximately one million bone-grafting procedures are performed every year on the pelvis, spine, and other body extremities. Higher incidence of bone and joint related disorders such as osteoporosis, arthritis, and other diseases such as obesity, diabetes, and cancer, cause injury to orthopedic tissues and affect the health and capability of the human skeleton. Bone and joint disorders account for almost half of debilitating conditions in individuals over 50 years of age. With this cohort of the population expected to double by the year 2020, demographics alone will represent a key growth driver. In addition, market for bone grafts will continue to be driven by the risks associated with the use of autograft bone, the need to achieve superior and optimum bone fusion, speedy patient recovery, need to eliminate multiple surgeries (in case of bone harvesting from the patient), rising number of spinal fusion procedures, growing use of tissue-engineered bone in joint replacements, commercialization of new, next generation bone growth factors, and launch of innovative new bone products, among others.

With the focus in the orthopedic industry shifting from the mechanics to the biology of bone healing, orthobiologics is bound to gain traction in the bone grafts market. There has already been a tremendous rise in the number of bone substitute products innovated and commercialized i.e. synthetic tissue/bone grafts, bone morphogenetic proteins (BMP), and platelet-rich plasma system, to name a few. Synthetic tissue technologies, unlike allografts are not contingent on the availability of donor tissue. Introduction of synthetic technologies utilizing recombinant technologies has the ability to stimulate tissue growth surrounding an implant.

Use of synthetic bone grafts is expected to continue to increase in the upcoming years, driven largely by multiple factors such as, cost-effectiveness, and improved physician understanding of clinical indications, and outcomes of synthetics. New breeds of synthetic bone grafts featuring biologically superior features, and characteristics will additionally help sustain its use into the future. Synthetic bone grafts market in the United States is expected to surge between the period 2010 to 2015, as stated by the recent report published by Global Industry Analysts Inc. Market for bone morphogenetic proteins (BMP, on the other hand, is forecast to grow significantly over the years 2006 through 2015.

Key players dominating the US bone grafts market include AlloSource, Biomet Inc, Interpore Cross International, BioMimetic Therapeutics Inc, DePuy Spine Inc, Exactech Inc, Integra LifeSciences Holdings Corporation, Integra OrthoBiologics, Lifelink Tissue Bank, LifeNet Health, Medtronic Inc, Medtronic Sofamor Danek Inc, Musculoskeletal Transplant Foundation, NovaBone Products LLC, NuVasive Inc, Orthovita Inc, Osiris Therapeutics Inc, Osteotech Inc, RTI Biologics Inc, Smith & Nephew Plc, Stryker Corporation, Synthes Inc, Wright Medical Technology Inc, and Zimmer Holdings Inc., among others.

The report titled "Bone Grafts: A US Market Report" published by Global Industry Analysts, Inc., provides a comprehensive review of industry structure, trends, issues, drivers, regulatory environment, product overview, and recent industry activity. Latent demand patterns are quantified across all product markets including Standard Allografts, Machine Bone Allografts, Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Platelet Concentrators and Synthetic Bone Grafts.

For more details about this research report, please visit

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press (at) StrategyR (dot) com
Web Site


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website